KELSEY BRIDENBAUGH: Open Payments
NPI 1598411381 · WASHINGTON COURT HOUSE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 45 payments from 12 companies in 2025. Trend: 2023 $296 · 2024 $754 · 2025 $717
Food & beverage: $672Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $256 |
| Lilly USA, LLC | 5 | $108 |
| PFIZER INC. | 4 | $73 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $64 |
| Astellas Pharma US Inc | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Abbott Laboratories | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
Products named: VRAYLAR, UBRELVY, Kerendia, MOUNJARO, NURTEC ODT, BREZTRI, Veozah, AIRSUPRA.
Industry payments across OH — which companies pay providers there.
